Status:
COMPLETED
Enhancing Collaboration Between Doctors and Patients to Improve Asthma
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Asthma
Lung Diseases
Eligibility:
All Genders
18-72 years
Phase:
NA
Brief Summary
The purpose of this study is to improve anti-inflammatory medication adherence and asthma outcomes by using reports of peak flow monitoring to prompt communication between patients and their doctors.
Detailed Description
BACKGROUND: Asthma is a chronic, potentially life-threatening disease that affects 17 million people in the United States. Asthma leads to millions of lost work days and thousands of hospitalizations...
Eligibility Criteria
Inclusion
- Asthma
- Currently using ICS
- Planning to live in the San Francisco Bay Area in the year following study entry
Exclusion
- Diagnosis of any lung disease other than asthma
- Has a smoking history greater than or equal to 15 pack-years
- Psychological problems that may make monthly study visits impossible
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT00201188
Start Date
December 1 2003
End Date
February 1 2008
Last Update
March 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco, Parnassus Campus
San Francisco, California, United States, 94143